Innervation of engineered structures

Patent metadata

Field	Value
Publication number	US-9993505-B2
Application number	US-201314375812-A
Country	US
Kind code	B2
Filing date	Jan 31, 2013
Priority date	Jan 31, 2012
Publication date	Jun 12, 2018
Grant date	Jun 12, 2018

Abstract

Methods of generating an innervated muscle structures are disclosed as well as bioengineered structures for tissue repair or regeneration. The methods can include the steps of obtaining populations of smooth muscle cells and neuronal progenitor cells and then seeding the cells together onto a matrix material, followed by culturing the seeded cells to form an innervated smooth muscle cell construct of directionally oriented smooth muscle cells. In one embodiment, the neuronal progenitor cells can be seeded first as neurospheres in a biocompatible solution, e.g., a collagen/laminin solution, and allowed to gel. Next, a second suspension of smooth muscle cells can be deposited as separate layer. Multiple layer structures of alternating muscle or neuron composition can also be formed in this manner. Differentiation of the neuronal progenitor cells can be induced by exposure to a differentiation medium, such as Neurobasal A medium and/or exposure to a differentiating agent, such as B-27 supplement. The innervated muscle structures can be disposed around a tubular scaffold, e.g., a chitosan-containing tube and further cultured to form tubular, bioengineered structures and two or more innervated muscle structures can be joined together to form an elongate composite structure.

First claim

What is claimed is:

1. A method of generating an innervated muscle construct comprising
obtaining smooth muscle cells;
obtaining neuronal progenitor cells;
preparing the neuronal progenitor cells by suspending the neuronal progenitor cells in a first matrix material comprising fibrin or collagen;
preparing the smooth muscle cells by suspending the smooth muscle cells in a second matrix material comprising fibrin or collagen;
seeding the cells by depositing the first and second cell-seeded matrix materials in contact with each other onto a culture plate;
inducing differentiation of the neuronal progenitor cells
culturing the seeded cells to form an innervated smooth muscle cell construct of directionally oriented smooth muscle cells; and
removing the innervated smooth muscle cell construct from the culture plate and disposing the innervated muscle construct around a tubular scaffold.

2. The method of claim 1 wherein the step of preparing the neuronal progenitor cells further comprises suspending the neuronal progenitor cells as neurospheres in a biocompatible solution.

3. The method of claim 1 wherein the step of preparing the neuronal progenitor cells further comprises suspending the neuronal progenitor cells in a collagen/laminin solution.

4. The method of claim 1 wherein the step of preparing the smooth muscle cells further comprises suspending the smooth muscle cells in a collagen solution.

5. The method of claim 1 wherein the step of inducing differentiation of the neuronal progenitor cells further comprises exposure to Neurobasal A medium.

6. The method of claim 1 wherein the step of inducing differentiation of the neuronal progenitor cells further comprises exposure to a B-27 supplement.

7. The method of claim 1 wherein the tubular scaffold comprises chitosan.

8. The method of claim 1 wherein the method further comprises connecting two or more of the innervated muscle constructs together to form an elongated composite construct.

9. The method of claim 1 wherein the method further comprises culturing the construct in a bioreactor until it exhibits contractions in response to contractile stimulation.

10. The method of claim 1 wherein the step of preparing the neuronal progenitor cells further comprises suspending the neuronal progenitor cells in a collagen solution.

11. The method of claim 10 further comprising allowing the neuronal progenitor cell/collagen solution to gel.

12. The method of claim 1 , wherein the culture plate has a central post to induce formulation of a tubular innervated smooth muscle cell construct.

13. The method of claim 12 wherein the method further comprises removing the tubular innervated muscle construct from the central post of the culture plate and disposing the construct around the tubular scaffold.

14. The method of claim 1 wherein the method further comprises connecting the innervated muscle construct to a non-innervated muscle construct to form an elongated composite construct.

15. The method of claim 14 further comprising allowing neural cells from the innervated muscle construct to infiltrate the non-innervated muscle construct.

Assignees

• Univ Wake Forest Health Sciences

Inventors

• Bitar Khalil

Classifications

• C12N2533/72

  Chitin, chitosan · CPC title

• C12N2533/54

  Collagen; Gelatin · CPC title

• C12N5/0661

  Smooth muscle cells · CPC title

• C12N5/0068

  General culture methods using substrates (for specific animal cell type C12N5/06) · CPC title

• A61L2430/30

  for muscle reconstruction · CPC title